Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · December 21, 2024

Risk of Malignancy in Patients With Psoriasis Treated With Long-Term TNF-α Inhibitor Therapy

Clinical and Experimental Dermatology

 

Additional Info

Clinical and Experimental Dermatology
The risk of malignancy in patients with psoriasis treated with long-term tumor necrosis factor-α inhibitor: a systematic review and meta-analysis
Clin Exp Dermatol 2024 Nov 29;[EPub Ahead of Print], WT Wu, MC Chiang, YC Huang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading